PRPH
PINK ProPhase Labs, Inc.$0.0090 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0090, and at the day’s high of $0.0098
- YTD change
- -97.99%
- vs 20-day SMA
- -26.78%
- vs 200-day SMA
- -92.79%
Price ranges
Price & Performance
-0.09 (-91.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $160.4000
- PRPH is down 98% since the beginning of the year
- PRPH is down 100% over the past 12 months
- PRPH is down 49% over the past 1 month
- 0% of all PRPH investors are betting against PRPH
PRPH reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -98.2%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0003
- Last 5 days
- -25.00%
- vs 8-day SMA
- -22.39%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Uniondale, NY.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
